BIOMAT Database Logo BIOMAT Database Logo

Warfarin-nafcillin interaction. 1991

R L Davis, and W Berman, and J A Wernly, and H W Kelly
College of Pharmacy, University of New Mexico, Albuquerque 87131.

UI MeSH Term Description Entries
D009254 Nafcillin A semi-synthetic antibiotic related to penicillin. Naphthamidopenicillin,Sodium Nafcillin,Nafcil,Nafcillin Sodium,Nafcillin, Monosodium Salt, Anhydrous,Nafcillin, Sodium,Sodium, Nafcillin
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

R L Davis, and W Berman, and J A Wernly, and H W Kelly
Possible nafcillin-warfarin interaction.
April 1994, Archives of internal medicine,
R L Davis, and W Berman, and J A Wernly, and H W Kelly
Significant drug-drug interaction between warfarin and nafcillin.
November 2018, Therapeutic advances in drug safety,
R L Davis, and W Berman, and J A Wernly, and H W Kelly
Continuation of warfarin-nafcillin interaction during dicloxacillin therapy.
August 1994, The Journal of family practice,
R L Davis, and W Berman, and J A Wernly, and H W Kelly
Decreased hypoprothrombinemic response to warfarin secondary to the warfarin-nafcillin interaction.
June 1991, DICP : the annals of pharmacotherapy,
R L Davis, and W Berman, and J A Wernly, and H W Kelly
Warfarin resistance with nafcillin therapy.
April 1984, Annals of internal medicine,
R L Davis, and W Berman, and J A Wernly, and H W Kelly
Interaction between warfarin and nafcillin: case report and review of the literature.
October 2007, Pharmacotherapy,
R L Davis, and W Berman, and J A Wernly, and H W Kelly
Warfarin resistance associated with nafcillin therapy.
August 1989, The American journal of medicine,
R L Davis, and W Berman, and J A Wernly, and H W Kelly
Interaction of aztreonam with nafcillin in intravenous admixtures.
September 1986, American journal of hospital pharmacy,
R L Davis, and W Berman, and J A Wernly, and H W Kelly
Warfarin danshen interaction.
March 1999, The Annals of thoracic surgery,
R L Davis, and W Berman, and J A Wernly, and H W Kelly
Sucralfate-warfarin interaction.
January 1992, The Annals of pharmacotherapy,
Copied contents to your clipboard!